NewsBenzingaWynnefield Capital披露持有Lifecore Biomedical约14.3%的股份,同意投票支持其待定合并,13D文件显示 Wynnefield Capital披露持有Lifecore Biomedical约14.3%的股份,同意投票支持其待定合并,13D文件显示 Benzinga 2026.09.29 20:18 (GMT+0) Open on Benzinga Other news What Are Wall Street Analysts' Target Price for Lumentum Holdings Stock? Texas Pacific Land Stock: Analyst Estimates & Ratings Keybanc Reiterates Sector Weight on NVIDIAto Sector Weight Top 3 Tech Stocks That May Fall Off A Cliff This Month Truist Securities Maintains Hold on BILL Holdings, Raises Price Target to $66 Nvidia’s China Exit Could Trigger a Bull-Bear Showdown: 6 Leveraged ETFs to Watch Wednesday